MGF (Mechano Growth Factor) Peptide

Mechano Growth Factor (MGF) is a splice variant of the insulin-like growth factor-1 (IGF-1) gene, specifically the IGF-1Ec isoform in humans (IGF-1Eb in rodents). Unlike systemic IGF-1, which is predominantly produced by the liver under growth hormone stimulation, MGF is expressed locally in skeletal muscle in response to mechanical loading, stretch, and damage. The 24-amino acid C-terminal E-domain peptide (sequence: YQPPSTNKNTKSQRRKGSTFEERK) is the focus of most research, as this region distinguishes MGF from mature IGF-1 and appears to mediate its unique biological actions.^[1]

Alternative Splicing and Local Expression
The IGF1 gene undergoes alternative splicing in response to mechanical signals. Inclusion of exon 5 produces the MGF transcript (IGF-1Ec), which encodes a precursor protein with a unique E-peptide. Research suggests that mechanical overload, eccentric contraction, and muscle damage all upregulate MGF mRNA within hours, preceding the slower rise of systemic IGF-1Ea. This temporal pattern positions MGF as an early-response factor in the muscle repair cascade.^[2]

Satellite Cell Activation
The most studied action of the synthetic MGF E-peptide is activation of muscle satellite cells (resident myogenic stem cells). In preclinical models, MGF has been shown to recruit quiescent satellite cells into the cell cycle, promoting proliferation prior to terminal differentiation. This is mechanistically distinct from mature IGF-1, which preferentially drives myoblast differentiation and fusion. The dual phases — MGF-mediated proliferation followed by IGF-1Ea-mediated differentiation — represent a coordinated regenerative program.^[1]

Receptor Pharmacology
The E-domain peptide does not appear to bind the IGF-1 receptor (IGF-1R) with high affinity. Research suggests MGF acts through a separate, as-yet incompletely characterized receptor or binding site, which may explain its distinct biological profile relative to full-length IGF-1. Downstream signaling has been associated with activation of PI3K/Akt pathways and modulation of MAPK signaling, contributing to anti-apoptotic effects in stressed myocytes and neurons.^[3]

Cytoprotective Signaling
In addition to satellite cell effects, the MGF E-peptide has been associated with neuroprotective and cardioprotective actions in preclinical models of ischemia. Research suggests it reduces apoptosis in vulnerable cell populations following hypoxic injury, an effect attributed to upregulation of anti-apoptotic Bcl-2 family proteins and suppression of caspase activation.^[3]

Comparison to IGF-1 and IGF-1 LR3
Whereas long-R3 IGF-1 (LR3) is engineered for prolonged systemic IGF-1R activation and broad anabolic signaling, MGF is studied as a short-acting, locally expressed regulator with a specialized role in satellite cell biology. The synthetic MGF peptide has a notably short plasma half-life (minutes), which has driven interest in PEGylated MGF analogs to extend exposure in research settings.^[2]

The following properties characterize the synthetic MGF E-domain peptide as supplied by AminoCore Research for in vitro and preclinical investigation.

Notes on Identity
The peptide marketed and studied as "MGF" in research settings refers specifically to the 24-residue C-terminal E-domain of the IGF-1Ec splice variant, not the full-length pro-IGF-1Ec protein. Investigators should note this distinction when comparing literature, as some studies refer to the full pro-peptide while research-grade synthetic MGF reflects only the unique E-domain sequence. The peptide is highly basic (multiple lysine and arginine residues), contributing to its short circulating half-life and rapid renal clearance in preclinical models.

MGF (Mechano Growth Factor) is supplied as a sterile lyophilized powder. As a 24-amino acid peptide containing multiple polar residues and a free N-terminus, it requires careful reconstitution to preserve structural integrity and biological activity in research applications. Proper handling minimizes peptide degradation, aggregation, and loss of activity due to surface adsorption.

Recommended Reconstitution Protocol:

1. Equilibrate the vial to room temperature (15-20 minutes) before opening to prevent moisture condensation on the lyophilized powder.
2. Briefly centrifuge the vial (if equipment is available) to ensure the lyophilized cake is at the bottom prior to opening.
3. Select reconstitution solvent: bacteriostatic water (0.9% benzyl alcohol) is the standard for research reconstitution. Sterile water or 0.9% sodium chloride may also be used for short-term studies.
4. Calculate concentration: for a 2 mg vial reconstituted with 1 mL of bacteriostatic water, the final concentration is 2 mg/mL (2000 µg/mL). Adjust solvent volume to achieve the desired working concentration.
5. Inject solvent slowly down the inner wall of the vial — do not direct the stream onto the lyophilized powder, which can cause foaming and denaturation.
6. Swirl gently until fully dissolved. Do not shake or vortex — mechanical agitation can shear peptide bonds and induce aggregation.
7. Inspect the solution: it should appear clear and colorless. Any visible particulates indicate compromised material that should not be used.

Compound-Specific Notes:

• MGF has a notably short half-life in solution — research data suggest functional activity declines within minutes to hours after reconstitution in physiological buffers, due to rapid proteolytic cleavage of the E-domain peptide.
• For in vitro experiments, reconstituted aliquots should be used immediately or stored at -20°C in single-use portions to avoid freeze-thaw cycles.
• Use low-binding polypropylene tubes for storage and dilution. Glass and high-binding plastics can cause significant peptide loss via surface adsorption.
• Avoid extended exposure to light or temperatures above 8°C once reconstituted.

All handling should be performed using appropriate personal protective equipment (PPE) including gloves and lab coat. MGF is for laboratory research use only and is not intended for human or veterinary administration.

Proper storage is critical for maintaining the structural integrity and biological activity of MGF (Mechano Growth Factor). As a 24-amino acid splice-variant peptide, MGF is sensitive to temperature fluctuations, moisture, and repeated freeze-thaw cycles. The following guidelines reflect standard practice for research-grade peptides of this class.

Lyophilized Powder Storage:

• Long-term (recommended): Store at -20°C or below in a frost-free freezer. Under these conditions, lyophilized MGF retains stability for 24 months or longer when protected from moisture and light.
• Short-term (up to 30 days): Store at 2-8°C in a sealed, desiccated container.
• Transit/shipping: Brief exposure to room temperature (≤7 days) during shipping does not significantly compromise lyophilized peptide quality.
• Keep the vial sealed and protected from light. Do not open until ready to reconstitute.

Reconstituted Solution Storage:

• 2-8°C: Reconstituted MGF should be used within 5-7 days when stored refrigerated in bacteriostatic water.
• -20°C (aliquoted): Single-use aliquots in low-binding polypropylene tubes can be stored for up to 30 days with minimal activity loss.
• Avoid repeated freeze-thaw cycles — each cycle can reduce active peptide concentration by 5-15% due to aggregation and proteolytic fragmentation.

Compound-Specific Stability Notes:

• MGF's C-terminal E-domain is highly susceptible to proteolytic cleavage in aqueous solution, particularly at physiological pH. This is the basis for its naturally short half-life in vivo and informs why fresh reconstitution is preferred for time-sensitive experiments.
• The peptide contains no cysteine residues, so disulfide-mediated aggregation is not a concern; however, the high content of polar and charged residues makes it prone to surface adsorption on glass and untreated plastic.
• Methionine and tryptophan residues are sensitive to oxidation — minimize exposure to atmospheric oxygen by keeping vials capped and storing under inert conditions when possible for extended studies.
• Avoid storage in standard household freezers with frequent door openings; temperature cycling accelerates degradation.

Adherence to these storage parameters supports reproducibility across in vitro and ex vivo MGF research applications.